Cargando…

Clozapine and hematologic adverse reactions: Impact of the Risk Evaluation and Mitigation Strategy program

INTRODUCTION: In October 2015, the Food and Drug Administration (FDA) instituted an update to the mandatory Risk Evaluation and Mitigation Strategy (REMS) program for clozapine to improve safety monitoring of hematologic events. However, the impact of the clozapine REMS program on reporting of hemat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borrelli, Eric P., Lee, Erica Y., Caffrey, Aisling R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213944/ https://www.ncbi.nlm.nih.gov/pubmed/32420002 http://dx.doi.org/10.9740/mhc.2020.05.070

Ejemplares similares

Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy
por: Curry, Brent, et al.
Publicado: (2018)

Time of onset of hematological side effects with Clozapine
por: Ktari, H., et al.
Publicado: (2022)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

The art and science of drug titration
por: Caffrey, Aisling R., et al.
Publicado: (2021)

Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
por: Skokou, Maria, et al.
Publicado: (2022)

Clozapine augmentation strategies
por: Roerig, James L.
Publicado: (2019)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Rare and very rare adverse effects of clozapine
por: De Fazio, Pasquale, et al.
Publicado: (2015)

Pericardial Effusion: Rare Adverse Effect of Clozapine
por: Bath, Anandbir S, et al.
Publicado: (2019)

Incidence of clozapine-induced hematological side effects in a Tunisian population
por: Shiri, M., et al.
Publicado: (2022)

Radiation effects and mitigation strategies for modern FPGAs
por: Stettler, Marc, et al.
Publicado: (2004)

SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program
por: Alford, Daniel P., et al.
Publicado: (2016)

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
por: Fleischman, William, et al.
Publicado: (2019)

Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
por: Projects, AMCP Special
Publicado: (2012)

Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine
por: Fukuyama, Kouji, et al.
Publicado: (2023)

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
por: Fukuyama, Kouji, et al.
Publicado: (2023)

No adverse events were observed in clozapine‐treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan
por: Hata, Masahiro, et al.
Publicado: (2021)

Comment on: Treatment strategies for clozapine-induced hypotension: A systematic review
por: Wieruszewski, Patrick M., et al.
Publicado: (2022)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Clozapine induced eosinophilia: An often neglected important adverse effect
por: Kadiyala, Pavan Kumar, et al.
Publicado: (2015)

Non-ischemic Cardiomyopathy: A Rare Adverse Effect of Clozapine
por: Garg, Abhinav, et al.
Publicado: (2020)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

Augmentation strategies for treatment-refractory clozapine patients
por: Freudenreich, O.
Publicado: (2021)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
por: Okada, Motohiro, et al.
Publicado: (2020)

Physician experiences with and perceptions of risk evaluation and mitigation strategy programs with elements to assure safe use
por: Sarpatwari, Ameet, et al.
Publicado: (2023)

The Importance of Gender-Neutral Terminology in Risk Evaluation and Mitigation Strategy Programs: A Call to Action
por: Burnette, Colin, et al.
Publicado: (2023)

Impact of Pharmacist Counselling on Clozapine Knowledge
por: Ní Dhubhlaing, Ciara, et al.
Publicado: (2017)

Impact of a Novel Strategy for Critical Values Communication for the Management of Patients Treated with Clozapine
por: Cano-Corres, Ruth, et al.
Publicado: (2021)

Patient and Caregiver Experiences With and Perceptions of Risk Evaluation and Mitigation Strategy Programs With Elements to Assure Safe Use
por: Sarpatwari, Ameet, et al.
Publicado: (2022)

Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report
por: Williams, Gabriela D.
Publicado: (2019)

Fairview Pharmacy Services clozapine monitoring program: Description and evaluation of a clinical pharmacy service
por: Heins, Katharine
Publicado: (2019)

The impact of COVID-19 on a cohort of patients treated with clozapine
por: Fahy, Y., et al.
Publicado: (2021)

Clozapine modifies the differentiation program of human adipocytes inducing browning
por: Kristóf, E, et al.
Publicado: (2016)

Prescribing clozapine and rifampicin: clinical impact of their interaction
por: Parker, Caroline
Publicado: (2016)

Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study
por: Yang, Lun, et al.
Publicado: (2011)

Treatment strategies for clozapine-induced hypotension: a systematic review
por: Tanzer, Timothy David, et al.
Publicado: (2022)

Clozapine in pregnancy
por: Sethi, Sujata
Publicado: (2006)

Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)

The Xyrem(®) (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017
por: Strunc, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sr6np03lj7452f71ar7ogtedrh